CN1080310C - 抗生素wap-8294a1、a2、a4、ax-8、ax-9和ax-13 - Google Patents

抗生素wap-8294a1、a2、a4、ax-8、ax-9和ax-13 Download PDF

Info

Publication number
CN1080310C
CN1080310C CN95115898A CN95115898A CN1080310C CN 1080310 C CN1080310 C CN 1080310C CN 95115898 A CN95115898 A CN 95115898A CN 95115898 A CN95115898 A CN 95115898A CN 1080310 C CN1080310 C CN 1080310C
Authority
CN
China
Prior art keywords
mole
acid
wap
reaction
microbiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN95115898A
Other languages
English (en)
Chinese (zh)
Other versions
CN1132252A (zh
Inventor
大桥良民
平田晴久
中谷清吾
加藤阿斯莎
相场勇志
小久保直美
铃木信之
前田孚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto Biological Pharmaceutical Co
Original Assignee
Japan Medical Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP01604495A external-priority patent/JP3339235B2/ja
Application filed by Japan Medical Research Corp filed Critical Japan Medical Research Corp
Publication of CN1132252A publication Critical patent/CN1132252A/zh
Application granted granted Critical
Publication of CN1080310C publication Critical patent/CN1080310C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN95115898A 1995-02-02 1995-08-18 抗生素wap-8294a1、a2、a4、ax-8、ax-9和ax-13 Expired - Lifetime CN1080310C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP01604495A JP3339235B2 (ja) 1994-02-18 1995-02-02 抗生物質ｗａｐ−８２９４ａ、その製造法及び抗菌剤
JP16044/95 1995-02-02

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB011196238A Division CN1196794C (zh) 1995-02-02 2001-05-15 抗生素wap－8294a和ax,其制备方法和抗菌组合物

Publications (2)

Publication Number Publication Date
CN1132252A CN1132252A (zh) 1996-10-02
CN1080310C true CN1080310C (zh) 2002-03-06

Family

ID=11905579

Family Applications (2)

Application Number Title Priority Date Filing Date
CN95115898A Expired - Lifetime CN1080310C (zh) 1995-02-02 1995-08-18 抗生素wap-8294a1、a2、a4、ax-8、ax-9和ax-13
CNB011196238A Expired - Lifetime CN1196794C (zh) 1995-02-02 2001-05-15 抗生素wap－8294a和ax,其制备方法和抗菌组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNB011196238A Expired - Lifetime CN1196794C (zh) 1995-02-02 2001-05-15 抗生素wap－8294a和ax,其制备方法和抗菌组合物

Country Status (6)

Country Link
KR (1) KR100225601B1 (ko)
CN (2) CN1080310C (ko)
AU (1) AU705610B2 (ko)
HK (1) HK1046155B (ko)
HU (1) HU218351B (ko)
NL (1) NL1001012C2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1292663C (zh) * 2005-10-21 2007-01-03 云南农业大学 一种防治植物细菌病害的生物制剂及其应用
CA2656604C (en) * 2006-06-29 2014-01-07 Arigen Pharmaceuticals, Inc. Injectable formulation of antibiotic and solution for intravenous administration thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588588A (en) * 1983-12-05 1986-05-13 E. R. Squibb & Sons, Inc. Antibiotic EM5487
EP0196042A2 (en) * 1985-03-25 1986-10-01 E.R. SQUIBB & SONS, INC. Antibiotic prepared from lysobacter sp. SC 14,067

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588588A (en) * 1983-12-05 1986-05-13 E. R. Squibb & Sons, Inc. Antibiotic EM5487
EP0196042A2 (en) * 1985-03-25 1986-10-01 E.R. SQUIBB & SONS, INC. Antibiotic prepared from lysobacter sp. SC 14,067

Also Published As

Publication number Publication date
HU218351B (hu) 2000-08-28
NL1001012C2 (nl) 1998-09-01
KR100225601B1 (ko) 1999-10-15
KR960030942A (ko) 1996-09-17
CN1132252A (zh) 1996-10-02
AU705610B2 (en) 1999-05-27
CN1196794C (zh) 2005-04-13
AU3012695A (en) 1996-08-08
HK1046155B (zh) 2005-09-30
HUT72397A (en) 1996-04-29
NL1001012A1 (nl) 1996-08-21
HU9502434D0 (en) 1995-10-30
CN1357631A (zh) 2002-07-10
HK1046155A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
CN1051757A (zh) 新的多肽化合物及其制备方法
CN1040054A (zh) 具有生物活性的新化合物及其制备方法
CN1300222A (zh) 策略性修饰的乙肝核心蛋白及其衍生物
CN1073359A (zh) 亲脂寡糖抗生素组合物
CN1242052C (zh) 诺卡氏菌的生物纯培养物
CN1193979A (zh) 大环内酯类化合物
CN1214106C (zh) 释放a氨基糖化的氨基酸的酶，产生该酶的菌体以及该酶的应用
CN87106876A (zh) 新抗生素
EP1814902B1 (en) Cyclosporine analogue
EP2261317B1 (en) Microorganism producing cyclic compound
JP3684432B2 (ja) アクタガルジンに関連した新規なランチビオティック、その製法およびその使用
CN1080310C (zh) 抗生素wap-8294a1、a2、a4、ax-8、ax-9和ax-13
CN85105429A (zh) 制备脱糖太科普兰宁(deglucoteicoplanin)的羧酸酯衍生物的方法
CN1023758C (zh) 含抗生素a10255复合物或其因子的饲料组合物
CN1053446C (zh) 新的thiomarinol衍生物及其制备方法
EP2261238B1 (en) Cyclic compound and salt thereof
CN1387566A (zh) 环状缩肽合成酶及其基因、以及环状缩肽的大规模生产系统
CN1031948C (zh) 抗生素ge2270的制备方法
CN1189478C (zh) 新的环状化合物
CN87105285A (zh) 新颖的抗生素及其加成盐
CN1012499B (zh) 抗菌素tan-749化合物的制备方法
CN85107903A (zh) 生产抗生素a40926复合物及其纯因子pa.pb.a.b.及b0的方法
CN1082956C (zh) 美加球菌素(Micacocidin)衍生物
JP3687929B2 (ja) 新規化合物ａ−７６２０２及びその製造法
CN1157482C (zh) 具有抗真菌活性的化合物及其制备方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Applicant after: Hitachi Medical Corp.

Applicant before: Wakamoto Pharmaceutical Co., Ltd.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: WAKAMOTO PHARMACEUTICAL CO., LTD. TO: HITACHI MEDICAL CORP.

C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: OREGAN CO., LTD.

Free format text: FORMER NAME OR ADDRESS: HITACHI MEDICAL CORP.

CP03 Change of name, title or address

Address after: Tokyo, Japan, Japan

Patentee after: Hitachi Medical Corp.

Address before: Tokyo, Japan, Japan

Patentee before: Hitachi Medical Corp.

C56 Change in the name or address of the patentee

Owner name: ALITO KIN PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME OR ADDRESS: OREGAN CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: Tokyo, Japan, Japan

Patentee after: Arigen Pharmaceuticals, Inc.

Address before: Tokyo, Japan, Japan

Patentee before: Hitachi Medical Corp.

ASS Succession or assignment of patent right

Owner name: LINK GENOMICS INC.

Free format text: FORMER OWNER: ARIGEN INC.

Effective date: 20130620

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20130620

Address after: Tokyo, Japan, Japan

Patentee after: Link Genomics, Inc.

Address before: Tokyo, Japan, Japan

Patentee before: Arigen Pharmaceuticals, Inc.

ASS Succession or assignment of patent right

Owner name: KYOTO BIOPHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: LINK GENOMICS INC.

Effective date: 20150216

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150216

Address after: Gifu County, Japan

Patentee after: Kyoto Biological Pharmaceutical Co

Address before: Tokyo, Japan, Japan

Patentee before: Link Genomics, Inc.

CX01 Expiry of patent term

Expiration termination date: 20150818

Granted publication date: 20020306

EXPY Termination of patent right or utility model